medigraphic.com
SPANISH

Revista Mexicana de Patología Clínica y Medicina de Laboratorio

ISSN 0185-6014 (Print)
Órgano oficial de difusión de la Federación Mexicana de Patología Clínica, AC y de la Asociación Latinoamericana de Patología Clínica/Medicina de Laboratorio
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2004, Number 1

<< Back Next >>

Rev Mex Patol Clin Med Lab 2004; 51 (1)

Clinical laboratory evaluation of the employment cystatin C as substitute test of the clearance creatinine

Herrera-Pérez E, Vigueras-Rueda E
Full text How to cite this article

Language: Spanish
References: 11
Page: 49-57
PDF size: 78.42 Kb.


Key words:

Cystatin C, creatinine clearance, Cockcroft-Gault formula.

ABSTRACT

Before introducing a new analytical method in the Clinical Laboratory, it should be verified its clinical usefulness already informed in literature. It has been described the serum Cystatin C measurement as means to evaluate glomerular filtration rate. In the clinical laboratory this evaluation is accomplished by creatinine clearance in 24 h urine sample measurement. In this work were compared results of measured creatinine clearance (urine-24 h) with obtained for serum Cys C from 100 patients (50 males; 50 females), ages 7-70 years old, referred to the lab. As comparison baseline for Cys C performance, the results obtained from calculated creatinine clearance (Cockcroft-Gault) were used. It was found that Cys C concentration correlated with measured creatinine clearance, being this results comparable statistically with calculated clearance creatinine. By this way, we concluded that Cys C may substitute, in the clinical laboratory, creatinine clearance measurement.


REFERENCES

  1. 1 Gaw A et al. Clinical chemistry. Second edition. Churchill Livingstone, 1999: 26-38.

  2. Newman DJ, Cystatin C. Personal view. Ann Clin Biochem 2002; 39: 89-104.

  3. Mussap M, Dalla M, Fioretto P et al. Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. Kidney Int 2002; 61: 1453-1461.

  4. Cockcroft D, Gault H. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41.

  5. Finney H, Newman DJ, Price CP. Adult reference ranges for serum cystatin C, creatinine and predicted creatinine clearance. Ann Clin Biochem 2000; 37: 49-59.

  6. Harmoinen A, Lehtimäki T et al. Diagnostic accuracyes of plasma creatinine, Cys C and glomerular filtration rate calculated by the Cockcroft-Gault and Levey (MDRD) formulas. Clin Chem 2003; 49: 1223-1225.

  7. Freund J. Modern elementary statistics. Eight edition. Prentice Hall Inc, 1992: 459-480.

  8. Dharnidharka V et al. Serum cystatin is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2002; 40: 221-228.

  9. National Kidney foundation K/DOQI. Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 2002; 39: S1-200.

  10. Newman D. More on Cystatin C. Clin Chem 1999; 45: 2556-7.

  11. Jayagopal V, Keevil B et al. Paradoxical changes in Cystatin C and serum creatinine in patients with hypo-and hyperthyroidism. Clin Chem 2003; 49: 680-681.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Patol Clin Med Lab. 2004;51